{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:57:57Z","timestamp":1770278277710,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ygyno.2013.08.015","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T19:17:59Z","timestamp":1377631079000},"page":"764-771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer"],"prefix":"10.1016","volume":"131","author":[{"given":"Chenguang","family":"Xi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caixia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuli","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.08.015_bb0005","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/IGC.0b013e318263f02e","article-title":"State of the science in ovarian cancer quality of life research: a systematic review","volume":"22","author":"Hess","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/jnci\/djp500","article-title":"Predictive value of symptoms for early detection of ovarian cancer","volume":"102","author":"Rossing","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2013.08.015_bb0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1525-1438.2005.00444.x","article-title":"Standard treatment in advanced ovarian cancer in 2005: the state of the art","volume":"15","author":"Bookman","year":"2005","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2013.08.015_bb0025","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/modpathol.3800306","article-title":"Origins and molecular pathology of ovarian cancer","volume":"18","author":"Bell","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1535-6108(01)00002-2","article-title":"Induction of ovarian cancer by defined multiple genetic changes in a mouse model system","volume":"1","author":"Orsulic","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0035","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0045","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0055","first-page":"567","article-title":"Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review)","volume":"16","author":"Aunoble","year":"2000","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7827-1-68","article-title":"Early events in ovarian oncogenesis","volume":"1","author":"Cvetkovic","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/geno.1998.5537","article-title":"Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human","volume":"54","author":"Peters","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0070","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1073\/pnas.83.24.9512","article-title":"Molecular cloning of protein 4.1, a major structural element of the human erythrocyte membrane skeleton","volume":"83","author":"Conboy","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0075","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1074\/jbc.275.5.3247","article-title":"Molecular and functional characterization of protein 4.1B, a novel member of the protein 4.1 family with high level, focal expression in brain","volume":"275","author":"Parra","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0080","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1523\/JNEUROSCI.19-15-06457.1999","article-title":"A novel neuron-enriched homolog of the erythrocyte membrane cytoskeletal protein 4.1","volume":"19","author":"Walensky","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00418-010-0749-z","article-title":"Comprehensive characterization of expression patterns of protein 4.1 family members in mouse adrenal gland: implications for functions","volume":"134","author":"Wang","year":"2010","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0090","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1046\/j.1523-1755.2003.00870.x","article-title":"Distinct distribution of specific members of protein 4.1 gene family in the mouse nephron","volume":"63","author":"Ramez","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0095","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1242\/jcs.00094","article-title":"Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation","volume":"115","author":"Sun","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1517\/14728222.12.7.845","article-title":"Potential role of EPB41L3 (protein 4.1B\/Dal-1) as a target for treatment of advanced prostate cancer","volume":"12","author":"Bernkopf","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-4598-5-4","article-title":"The tumor suppressor DAL-1\/4.1B and protein methylation cooperate in inducing apoptosis in MCF-7 breast cancer cells","volume":"5","author":"Jiang","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1593\/neo.10340","article-title":"Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers","volume":"12","author":"Dafou","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0115","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.0705499104","article-title":"Protein 4.1B suppresses prostate cancer progression and metastasis","volume":"104","author":"Wong","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0969-9961(03)00071-8","article-title":"Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis","volume":"13","author":"Robb","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0125","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1182\/blood-2008-10-182329","article-title":"Cytoskeletal protein 4.1R negatively regulates T-cell activation by inhibiting the phosphorylation of LAT","volume":"113","author":"Kang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0130","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3892\/etm.2012.653","article-title":"The membrane-cytoskeletal protein 4.1N is involved in the process of cell adhesion, migration and invasion of breast cancer cells","volume":"4","author":"Ji","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbamem.2005.01.013","article-title":"Nectin-like molecule 1 is a protein 4.1N associated protein and recruits protein 4.1N from cytoplasm to the plasma membrane","volume":"1669","author":"Zhou","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0140","doi-asserted-by":"crossref","first-page":"10747","DOI":"10.1523\/JNEUROSCI.19-24-10747.1999","article-title":"Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor","volume":"19","author":"Ye","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0150","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1158\/0008-5472.CAN-03-3380","article-title":"A genetically defined model for human ovarian cancer","volume":"64","author":"Liu","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0155","first-page":"5379","article-title":"Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors","volume":"43","author":"Hamilton","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0160","first-page":"680","article-title":"Establishment of human ovarian cancer cisplatin resistant cell line COC1\/DDP and its mechanism of resistance","volume":"76","author":"Zhou","year":"1996","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0165","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1242\/jcs.000273","article-title":"Evidence for protein 4.1B acting as a metastasis suppressor","volume":"120","author":"Cavanna","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ijc.10470","article-title":"Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells","volume":"100","author":"Charboneau","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0175","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/1078-0432.CCR-04-2206","article-title":"Promoter methylation of DAL-1\/4.1B predicts poor prognosis in non-small cell lung cancer","volume":"11","author":"Kikuchi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0180","doi-asserted-by":"crossref","first-page":"10052","DOI":"10.1128\/MCB.25.22.10052-10059.2005","article-title":"Loss of the putative tumor suppressor band 4.1B\/Dal1 gene is dispensable for normal development and does not predispose to cancer","volume":"25","author":"Yi","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0185","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ijc.21450","article-title":"Promoter hypermethylation of the potential tumor suppressor DAL-1\/4.1B gene in renal clear cell carcinoma","volume":"118","author":"Yamada","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0190","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mc.20316","article-title":"Hypermethylation of the Dal-1 gene in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats","volume":"46","author":"Tsujiuchi","year":"2007","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-4598-6-14","article-title":"Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer","volume":"6","author":"Schulz","year":"2007","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0200","doi-asserted-by":"crossref","first-page":"932371","DOI":"10.1155\/2010\/932371","article-title":"Ovarian cancer pathogenesis: a model in evolution","volume":"2010","author":"Karst","year":"2010","journal-title":"J Oncol"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0205","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/onc.2009.402","article-title":"Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis","volume":"29","author":"Levanon","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0210","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0215","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1074\/jbc.M110.174011","article-title":"Structural basis of tumor suppressor in lung cancer 1 (TSLC1) binding to differentially expressed in adenocarcinoma of the lung (DAL-1\/4.1B)","volume":"286","author":"Busam","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2013.08.015_bb0220","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.bbamem.2009.03.022","article-title":"Protein 4.1R links E-cadherin\/beta-catenin complex to the cytoskeleton through its direct interaction with beta-catenin and modulates adherens junction integrity","volume":"1788","author":"Yang","year":"2009","journal-title":"Biochim Biophys Acta"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813011001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813011001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T05:13:25Z","timestamp":1563772405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813011001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0090825813011001"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.08.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}